Search

Your search keyword '"Erra, Alba"' showing total 133 results

Search Constraints

Start Over You searched for: Author "Erra, Alba" Remove constraint Author: "Erra, Alba"
133 results on '"Erra, Alba"'

Search Results

1. Seven-chain adaptive immune receptor repertoire analysis in rheumatoid arthritis reveals novel features associated with disease and clinically relevant phenotypes

2. Interactions between rheumatoid arthritis antibodies are associated with the response to anti-tumor necrosis factor therapy

3. Measuring inflammation in rheumatoid arthritis with a new clinical and ultrasound index: development and initial validation

4. Lipoprotein(a) concentrations in rheumatoid arthritis on biologic therapy: Results from the CARdiovascular in rheuMAtology study project

6. Nailfold capillaroscopic findings in primary Sjögren’s syndrome with and without Raynaud’s phenomenon and/or positive anti-SSA/Ro and anti-SSB/La antibodies

7. Longitudinal analysis of blood DNA methylation identifies mechanisms of response to tumor necrosis factor inhibitor therapy in rheumatoid arthritis

8. Longitudinal analysis of blood DNA methylation identifies mechanisms of response to tumor necrosis factor inhibitor therapy in rheumatoid arthritis

9. Seven chain adaptive immune receptor repertoire analysis in rheumatoid arthritis: association to disease and clinically relevant phenotypes

10. Identification of IRX1 as a Risk Locus for Rheumatoid Factor Positivity in Rheumatoid Arthritis in a Genome-Wide Association Study

11. A deletion at ADAMTS9-MAGI1 locus is associated with psoriatic arthritis risk

12. PDE3A-SLCO1C1 locus is associated with response to anti-tumor necrosis factor therapy in psoriatic arthritis

13. Additional file 1 of Interactions between rheumatoid arthritis antibodies are associated with the response to anti-tumor necrosis factor therapy

14. Interactions Between Rheumatoid Arthritis Antibodies Are Associated With the Response to Anti-tumor Necrosis Factor Therapy

15. GWAS replication study confirms the association of PDE3A–SLCO1C1 with anti-TNF therapy response in rheumatoid arthritis

16. Risk variants for psoriasis vulgaris in a large case–control collection and association with clinical subphenotypes

17. Incidence of COVID-19 in a cohort of adult and paediatric patients with rheumatic diseases treated with targeted biologic and synthetic disease-modifying anti-rheumatic drugs

20. Blood RNA sequencing reveals immunological processes associated with the response to abatacept in rheumatoid arthritis

21. Incidence of first cardiovascular event in Spanish patients with inflammatory rheumatic diseases: prospective data from the CARMA Project

23. A combined transcriptomic and genomic analysis identifies a gene signature associated with the response to anti-TNF therapy in rheumatoid arthritis

25. A Combined Transcriptomic and Genomic Analysis Identifies a Gene Signature Associated With the Response to Anti-TNF Therapy in Rheumatoid Arthritis

27. SAT0020 BLOOD RNA SEQUENCING REVEALS IMMUNOLOGICAL PROCESSES ASSOCIATED WITH THE RESPONSE TO ABATACEPT IN RHEUMATOID ARTHRITIS

28. SAT0616 DIETARY HABITS OF SIX AUTOIMMUNE DISEASES IN THE SPANISH POPULATION: A CROSS-SECTIONAL STUDY

29. Genetic variation at the glycosaminoglycan metabolism pathway contributes to the risk of psoriatic arthritis but not psoriasis

30. Concordance between direct and indirect measurements of free 25-OH vitamin D

31. Association Between Vitamin D Status and Schizophrenia

32. Lipoprotein(a) concentrations in rheumatoid arthritis on biologic therapy: Results from the CARdiovascular in rheuMAtology study project

33. Additional file 1: Table S1. of Variation at interleukin-6 receptor gene is associated to joint damage in rheumatoid arthritis

34. Impact of Comorbidity on Physical Function in Patients With Ankylosing Spondylitis and Psoriatic Arthritis Attending Rheumatology Clinics: Results From a Cross‐Sectional Study

35. Genetic variation at the glycosaminoglycan metabolism pathway contributes to the risk of psoriatic arthritis but not psoriasis.

36. Identification ofIRX1as a Risk Locus for Rheumatoid Factor Positivity in Rheumatoid Arthritis in a Genome-Wide Association Study

37. A genome-wide association study identifiesSLC8A3as a susceptibility locus for ACPA-positive rheumatoid arthritis

38. Variation at interleukin-6 receptor gene is associated to joint damage in rheumatoid arthritis

39. Variation at interleukin-6 receptor gene is associated to joint damage in rheumatoid arthritis

40. A deletion atADAMTS9-MAGI1locus is associated with psoriatic arthritis risk

41. Variation at FCGR2A and Functionally Related Genes Is Associated with the Response to Anti-TNF Therapy in Rheumatoid Arthritis

42. Switching TNF antagonists in patients with chronic arthritis: An observational study of 488 patients over a four-year period

44. A genome-wide association study identifies SLC8A3 as a susceptibility locus for ACPA-positive rheumatoid arthritis.

45. Reference intervals for bone turnover markers in Spanish premenopausal women.

47. Genome-wide association study of rheumatoid arthritis in the Spanish population:KLF12as a risk locus for rheumatoid arthritis susceptibility

50. PDE3A-SLCO1C1 locus is associated with response to anti-tumor necrosis factor therapy in psoriatic arthritis.

Catalog

Books, media, physical & digital resources